Zay Yar Htay
Hospitalist · Pomona, CANPI 1811395965
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 26.0% of the total. Reporting peaked in 2021 at $432 and has fallen 53.3% since, to $202 in 2025. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$350
- Johnson & Johnson$296
- Kestra Medical Technology Services, Inc.$169
- Novartis$136
- AstraZeneca$96
- Otsuka America Pharmaceutical, Inc.$63
- plus $239 from 8 others
What the payments were for
- Food & beverage$1,349100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 21 | $350 |
| Johnson & Johnson | 17 | $296 |
| Kestra Medical Technology Services, Inc. | 22 | $169 |
| Novartis | 6 | $136 |
| AstraZeneca | 6 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $55 |
| Smith+Nephew | 2 | $48 |
| Boston Scientific | 1 | $43 |
| Merck | 1 | $24 |
| Abbott | 1 | $23 |
| AbbVie | 1 | $21 |
| Boehringer Ingelheim | 1 | $14 |
| CMP Pharma, Inc. | 1 | $12 |
How this compares
$1,349 in reported general payments places this provider in the 90th percentile of 2,469 hospitalist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $14,522 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $481 |
| Pantoprazole Sodium | 40 | $154 |
| Ondansetron Hcl | 34 | $151 |
| Atorvastatin Calcium | 30 | $116 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $96 |
| Nitroglycerin | 15 | $94 |
| Hydralazine Hcl | 20 | $89 |
| Amlodipine Besylate | 33 | $71 |
| Cephalexin | 12 | $60 |
| Metoprolol Tartrate | 22 | $47 |
| Gabapentin | 12 | $45 |
| Furosemide | 17 | $40 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Pomona
- Gary SandhuPomona$4K
- Jennifer SchneiderSanta Rosa$1.2M
- Soham ShahBakersfield$844K
- Alpesh AminOrange$428K
- Retha GoodglickSanta Monica$156K
- Robert WachterSan Francisco$75K
- Steven WongTorrance$36K
- Edward LeeLos Angeles$30K
- Anjani KolahiOrange$30K
- Omar AldaasSan Diego$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.